GSK spies indicted in China for illegally obtaining information

15 July 2014
medical_legal_law_big

A couple allegedly working for UK pharma major GlaxoSmithKline (LSE: GSK) in China have been indicted in Shanghai for illegally obtaining private information from Chinese citizens, reported Xinhua News Agency.

The couple, Peter Humphrey, who is British, 58, and his wife Yu Ying Zeng, a 61-year old from the USA, were hired by GSK last year and arrested in August.

GSK faces legal challenge in China

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical